EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience

Fedele Dono, Giacomo Evangelista, Davide Rodorigo, Eleonora Rollo, Marina Romozzi, Clarissa Corniello, Davide Liviello, Michelangelo Dasara, Luca Capriati, Paolo Quintieri, Serenella Servidei, Giacomo Della Marca und 3 weitere

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109951 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Fedele Dono und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy; Behavioral Neurology and Mole…. Hauptthemen laut MEDLINE: Anticonvulsants, Status Epilepticus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Status Epilepticus (SE) can occur in patients without a previous epilepsy diagnosis, a condition identified as "new-onset status epilepticus" (NOSE). Treatment with benzodiazepine may fail in NOSE termination, requiring anti-seizure medication (ASM) employment. The term "established NOSE" (eNOSE) is generally employed in this context. This study aims to describe the main clinical characteristics of a large sample of patients suffering from eNOSE, compare the ASM efficacy, and explore the risk factors associated with ASM treatment unresponsiveness and eNOSE-associated mortality. METHODS: Adult patients diagnosed with eNOSE were retrospectively selected between January 2016 and December 2022. We reviewed demographics, clinical data, diagnostic work-up, and treatment. We considered the last ASM introduced before the eNOSE termination as effective. RESULTS: 123 patients were included (age: 67.9 ± 17.3). eNOSE acute etiology was mostly reported. In the overall cohort, phenytoin showed the highest response rate (p = 0.01). In the pairwise comparisons, valproate was superior to levetiracetam (p = 0.02) but not to lacosamide (p = 0.50). Phenytoin had a significantly higher resolution rate than levetiracetam (p = 0.001) but not lacosamide (p = 0.14). Thirty patients were refractory to ASM treatment. No predictors of refractoriness were identified. Thirty-nine patients died. Age and GCS were identified as eNOSE-related mortality risk factors. CONCLUSION: eNOSE frequently has an acute etiology with several associated syndromes. Phenytoin is more effective in managing eNOSE, even though lacosamide, valproate, and levetiracetam can represent further therapeutic options. Age and GCS are the main risk factors for eNOSE-associated mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsStatus EpilepticusAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedLevetiracetamPhenytoinRetrospective StudiesRisk FactorsTreatment OutcomeValproic Acid

Stichwörter der Autor:innen

EpilepsyOutcomeRefractorinessStatus EpilepticusTreatment

Substanzen

AnticonvulsantsLevetiracetamPhenytoinValproic Acid

Autor:innen und Institutionen

  • Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy; Behavioral Neurology and Molecular Neurology Units, Center for Advanced Studies and Technology-CAST…
  • Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Dipartimento di Neuroscienze, Organi di Senso e Torace, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Dipartimento di Neuroscienze, Organi di Senso e Torace, Università Cattolica del Sacro Cuore, Rome, Italy; Neurofisiopatologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Policlinico Universitario Agostino…
  • Dipartimento di Neuroscienze, Organi di Senso e Torace, Università Cattolica del Sacro Cuore, Rome, Italy; Neurologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Policlinico Universitario Agostino Gemelli I…

Zitieren

APA

Dono, F., Evangelista, G., Rodorigo, D., Rollo, E., Romozzi, M., Corniello, C., Liviello, D., Dasara, M., Capriati, L., Quintieri, P., Servidei, S., Della Marca, G., Calabresi, P., Sensi, S. L., & Vollono, C. (2024). Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109951

Vancouver

Dono F, Evangelista G, Rodorigo D, Rollo E, Romozzi M, Corniello C, et al. Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109951

BibTeX
@article{Dono2024,
  author = {Dono, Fedele and Evangelista, Giacomo and Rodorigo, Davide and Rollo, Eleonora and Romozzi, Marina and Corniello, Clarissa and Liviello, Davide and Dasara, Michelangelo and Capriati, Luca and Quintieri, Paolo and Servidei, Serenella and Della Marca, Giacomo and Calabresi, Paolo and Sensi, Stefano L and Vollono, Catello},
  title = {Clinical characteristics and treatment approach of established New-Onset status epilepticus (eNOSE): A Real-World multicenter experience},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109951}
}
Kostenlos starten →